Hello, everyone, and how are you today? A shiny day is unfolding on the Pharmalot corporate campus where, once again, we are scrambling to deliver the short people to the local school house. And, of course, we are quaffing our mandatory cup of stimulation. This will be a particularly busy day as we tend to podcast matters. Meanwhile, here is the news of the world. Hope your day goes well...
Drugmakers Replace Reps With Digital Tools (Wall Street Journal)
Pfizer's Chantix Blamed For Murder-Suicide In Lawsuit (Pittsburgh Post-Gazette)
Sanofi Wins FDA OK For Short Needle Flu Vaccine (Reuters)
NSAIDs May Raise Risks After Heart Attack (Health Day)
MannKind Narrow Quarterly Loss While Awaiting FDA OK (Associated Press)
Aurobindo Pharma Considers Spin Offs (Wall Street Journal)
US Attacks On New Zealand Agency Draws Anger (Pharma Times)
Abbott Recalls Device Used To Clip Heart Valves (Dow Jones)
Overseas Clinical Trials Draw Scrutiny And Concern (Reuters)
FDA And USP Extend Relationship (InPharma Technologist)
Quest Pays $241M To Settle Overbilling Lawsuit (Reuters)
Pfizer Studies Back Prevnar 13 Vaccine For Adults (Associated Press)
Takeda Buys Fate Therapeutics In Stem Cell Bid (Pharma Times)
EDITOR’S NOTE: Please check this post for updates throughout the morning
1 Comment
Reuters article re flu shot still citing the "Sanofi Aventis" identity.